[Postprandial lipemia under treatment with Allium sativum. Controlled double-blind study of subjects with reduced HDL2-cholesterol]
- PMID: 1472142
[Postprandial lipemia under treatment with Allium sativum. Controlled double-blind study of subjects with reduced HDL2-cholesterol]
Abstract
Postprandial Lipaemia under Treatment with Allium sativum/Controlled double-blind study in healthy volunteers with reduced HDL2-cholesterol levels. The effectiveness of a standardized garlic powder preparation (Sapec, Kwai) on alimentary hypertriglyceridaemia after intake of a standardized fatty test meal containing 100 g butter was analyzed in a randomized placebo-controlled double-blind study. 24 volunteers with HDL2-cholesterol concentrations in plasma of less than 10 mg/dl (men) respectively 15 mg/dl (women) participated in the study. The volunteers received 3 times 1 tablet daily over a period of 6 weeks equivalent to a daily dosage of 900 mg garlic powder in the active treated group. Control measurements were made on the 1st, 22nd and 43rd day of treatment and 0, 3 and 5 h after intake of the meal. The postprandial increase of triglycerides was clearly reduced under garlic medication as compared to placebo treatment. The determined AUC-values for the triglycerides were up to 35% lower in the garlic group compared to the placebo group. The regular intake of the garlic preparation over the period of 6 weeks showed a significant lowering of the fasting values of triglycerides in comparison to placebo. Under garlic medication HDL2-cholesterol increased more than under placebo in tendency.
Similar articles
-
Garlic as a lipid lowering agent--a meta-analysis.J R Coll Physicians Lond. 1994 Jan-Feb;28(1):39-45. J R Coll Physicians Lond. 1994. PMID: 8169881 Free PMC article.
-
Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study.Arzneimittelforschung. 1990 Oct;40(10):1111-6. Arzneimittelforschung. 1990. PMID: 2291748 Clinical Trial.
-
No effect of garlic extract supplement on serum lipid levels in hypercholesterolemic subjects.J Med Assoc Thai. 2003 Aug;86(8):750-7. J Med Assoc Thai. 2003. PMID: 12948274 Clinical Trial.
-
Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.Clin Ther. 2005 Jun;27(6):715-27. doi: 10.1016/j.clinthera.2005.06.017. Clin Ther. 2005. PMID: 16117978 Clinical Trial.
-
[Mediterranean nutrition: a model for the world?].Arch Mal Coeur Vaiss. 1992 Sep;85 Spec No 2:135-8. Arch Mal Coeur Vaiss. 1992. PMID: 1285693 Review. French.
Cited by
-
Garlic as a lipid lowering agent--a meta-analysis.J R Coll Physicians Lond. 1994 Jan-Feb;28(1):39-45. J R Coll Physicians Lond. 1994. PMID: 8169881 Free PMC article.
-
Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007653. doi: 10.1002/14651858.CD007653.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895963 Free PMC article.
-
Role of garlic usage in cardiovascular disease prevention: an evidence-based approach.Evid Based Complement Alternat Med. 2013;2013:125649. doi: 10.1155/2013/125649. Epub 2013 Apr 17. Evid Based Complement Alternat Med. 2013. PMID: 23690831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical